U.S. markets closed

Ocuphire Pharma, Inc. (OCUP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.2000-0.1100 (-2.55%)
At close: 4:00PM EDT
4.2900 +0.09 (2.14%)
After hours: 07:59PM EDT
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
Total Revenue
0
0
0
Operating Expense
14,043
9,466
4,193
Operating Income
-14,043
-9,466
-4,193
Net Non Operating Interest Income Expense
-6,293
-6,847
-1,409
Other Income Expense
-40,210
-8,307
-567
Pretax Income
-60,546
-24,620
-6,169
Tax Provision
0
0
0
Net Income Common Stockholders
-60,546
-24,620
-6,169
Diluted NI Available to Com Stockholders
-60,546
-24,620
-6,169
Basic EPS
-
-5.28
-0.87
Diluted EPS
-
-5.28
-0.87
Basic Average Shares
-
4,661
7,092
Diluted Average Shares
-
4,661
7,092
Total Operating Income as Reported
-22,419
-19,968
-4,193
Total Expenses
14,043
9,466
4,193
Net Income from Continuing & Discontinued Operation
-60,546
-24,620
-6,169
Normalized Income
-20,329
-16,304
-5,670
Interest Expense
6,293
6,847
1,409
Net Interest Income
-6,293
-6,847
-1,409
EBIT
-54,253
-17,773
-4,760
EBITDA
-54,249
-
-
Reconciled Depreciation
4
8
3
Net Income from Continuing Operation Net Minority Interest
-60,546
-24,620
-6,169
Total Unusual Items Excluding Goodwill
-40,217
-8,316
-499
Total Unusual Items
-40,217
-8,316
-499
Normalized EBITDA
-14,032
-9,449
-4,258
Tax Rate for Calcs
0
0
0
Tax Effect of Unusual Items
0
0
0